The Collaborative Research Center (CRC) 1648 investigates emerging viruses – viruses that were previously unknown or that appear for the first time in a specific region or among humans. Such pathogens can have significant impacts on health, as we saw during the COVID-19 pandemic.
The central hypothesis of this CRC is that an in-depth understanding of pathogenesis, structural and functional aspects of virus-host interactions, and immunity to specific emerging viral infections will allow for the strategic development of widely applicable and generalizable preventive or therapeutic strategies targeting both virus and host.